Recent research reveals Parabacteroides goldsteinii in the gut contributes to age-related cognitive decline through vagal inflammation, offering potential reversible therapies via microbiome modulatio...
Recent 2023 research shows age-related gut microbiome shifts drive brain inflammation and cognitive decline, with fecal microbiota transplantation and anti-inflammatory diets emerging as promising ant...
A groundbreaking study reveals that depleting the gut microbiome in aged mice improves memory and reduces brain inflammation, highlighting the gut-brain axis as a target for non-invasive aging interve...
Recent research confirms TDP-43 aggregation in vascular dementia, with advancements in biomarkers and therapies highlighting potential for early intervention and personalized prevention. New studies r...
The cGAS-STING pathway, crucial for innate immunity, drives harmful neuroinflammation in aging and Alzheimer’s, with recent studies highlighting therapeutic challenges and biomarker potential fo...
This article explores how senotherapeutics target senescent cells in the brain to reduce neuroinflammation and improve cognition, based on recent preclinical studies and emerging clinical trials. Emer...
A 2025 study shows CEMIP blocks remyelination by producing hyaluronan fragments, linking multiple sclerosis to cognitive aging and opening new therapy avenues for brain health. Recent research uncover...
The shift from stem cell transplants to extracellular vesicles offers enhanced stability, easier storage, and scalable production, potentially improving treatment accessibility for conditions like Alz...
Recent UCLA research reveals curcumin’s 18% memory improvement in cognitive impairment cases. Advanced delivery systems like nanoemulsions overcome bioavailability challenges, reshaping dietary appr...
New research reveals curcumin’s ability to combat brain inflammation via microglial modulation, with enhanced bioavailability through piperine. Experts weigh in on optimal dosing and emerging nano-f...
